The fluoroquinolone antibacterials: past, present and future perspectives
Top Cited Papers
- 21 August 2000
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 16 (1), 5-15
- https://doi.org/10.1016/s0924-8579(00)00192-8
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Decreased Susceptibility ofStreptococcus pneumoniaeto Fluoroquinolones in CanadaNew England Journal of Medicine, 1999
- Comparative Tolerability of the Newer Fluoroquinolone AntibacterialsDrug Safety, 1999
- Comparison of the antibacterial activities of the quinolones Bay 12- 8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin [published erratum appears in J Antimicrob Chemother 1998 Jun;41(6):672]Journal of Antimicrobial Chemotherapy, 1997
- Quinolones: structure-activity relationships and future predictionsJournal of Medical Microbiology, 1996
- Quinolone Activity against AnaerobesDrugs, 1995
- Structure-activity and structure-side-effect relationships for the quinolone antibacterialsJournal of Antimicrobial Chemotherapy, 1994
- Comparative activity of the new fluoroquinolone bay y3118 against 177 penicillin susceptible and resistant pneumococciEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- Structure-activity relationships in DNA gyrase inhibitorsPharmacology & Therapeutics, 1990
- The activity of ciprofloxacin and other 4-quinolones againstChlamydia trachomatis andMycoplasmas in vitroEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- In vitro activities of ciprofloxacin, norfloxacin, pipemidic acid, cinoxacin, and nalidixic acid against Chlamydia trachomatisAntimicrobial Agents and Chemotherapy, 1984